SS Innovations International (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system will be featured at the 2026 Society of Robotic Surgery Annual Meeting, taking place July 23-26 in Hollywood, Florida. The system will be displayed throughout the event and highlighted in multiple breakout sessions. It will also be used in a live broadcast of a remote partial nephrectomy performed by Dr. Amitabh Singh from the company’s headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi.
Chairman and CEO Dr. Sudhir Srivastava will participate as a speaker and panelist in multiple sessions covering telesurgery, robotic surgery adoption, regulatory frameworks, and global access to robotic care. As of July 6, 2026, the SSi Mantra system had been used in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries, while approximately 2,100 physicians have been trained on the platform.
To view the full press release, visit https://ibn.fm/YYYKE. About SS Innovations: SS Innovations International, Inc. develops innovative surgical robotic technologies with a vision to make robotic surgery affordable and accessible globally. Its product range includes the SSi Mantra surgical robotic system and the SSi Mudra surgical instruments, supporting various procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand its global presence with its technologically advanced, user-friendly, and cost-effective solutions.
These results highlight the growing adoption of the SSi Mantra system, which has demonstrated versatility across a wide range of surgical specialties. The live telesurgery broadcast underscores the system's capability for remote procedures, which could expand access to robotic surgery in underserved regions. The company's participation in regulatory and access discussions at the conference signals its intent to navigate the complex landscape of global healthcare markets.
Forward-looking statements in this article are subject to risks and uncertainties as outlined in the company's SEC filings. Please see full terms of use and disclaimers on the InvestorBrandNetwork website at http://IBN.fm/Disclaimer.
